Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Iris Y. Sheng
Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
Case Reports in Oncological Medicine
Oncology
Related publications
Role of Immunotherapy in Triple-Negative Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer
Cancer Management and Research
Oncology
Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go From Here
Cancer
Cancer Research
Oncology
Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Recurrent Triple-Negative Breast Cancer (TNBC) Tissues Contain a Higher Amount of Phosphatidylcholine (32:1) Than Non-Recurrent TNBC Tissues
PLoS ONE
Multidisciplinary
Targeting MYC for Triple-Negative Breast Cancer Treatment
Oncoscience
Cancer Research
Oncology
Triple-Negative Breast Cancer
Germline TP53 and MSH6 Mutations Implicated in Sporadic Triple-Negative Breast Cancer (TNBC): A Preliminary Study
Human Genomics
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
Tissue Factor as a New Target for CAR-NK Cell Immunotherapy of Triple-Negative Breast Cancer
Scientific Reports
Multidisciplinary